A phase i study of intravenous iododeoxyuridine as a clinical radiosensitizer
- 30 November 1985
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 11 (11), 1941-1946
- https://doi.org/10.1016/0360-3016(85)90275-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A phase i study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Nonlinear pharmacokinetic models for 5-fluorouracil in man: Intravenous and intraperitoneal routesClinical Pharmacology & Therapeutics, 1980
- High‐dose intravenous and hepatic artery infusions of thymidineClinical Pharmacology & Therapeutics, 1978
- Comparison of Intravenous and Intra-arterial Pyrimidine Infusion as a Means of Radiosensitizing TumorsIn VivoRadiology, 1977
- Failure of High Dose 5-Iodo-2′-Deoxyuridine in the Therapy of Herpes Simplex Virus EncephalitisNew England Journal of Medicine, 1975
- Relation between the pathological nature and the growth rate of human tumorsEuropean Journal of Cancer (1965), 1971
- Radiosensitization of Malignant Brain Tumours with Bromouridine (Thymidine Analogue)Acta Radiologica: Therapy, Physics, Biology, 1969
- Radiosensitization Of E. Coli by Purine and Pyrimidine Analogues Incorporated in Deoxyribonucleic AcidNature, 1961
- Molecular radiobiology of human cell lines. I. Comparative sensitivity to X-rays and ultraviolet light of cells containing halogen-substituted DNABiochemical and Biophysical Research Communications, 1961
- GENETICS OF HUMAN CELL LINESThe Journal of Experimental Medicine, 1960